Contour Neurovascular System™

Targets the neck of the aneurysm

Designed to treat a range of aneurysm morphologies including unruptured wide-necked bifurcation and bifurcation aneurysms:

  • Provides a combination of flow diversion at the neck of the aneurysm and flow disruption within the aneurysm sac;

  • Supports neo-intimal growth across mesh at neck and subsequent thrombosis of aneurysm;

  • Deployed with proven existing clinical techniques;

  • A single device occlusion that is re-sheathable & re-deployable;

  • Electrolytic method of detachment;

  • Strong IP portfolio - 3 patents issued and 3 patents pending;

  • No intra-arterial stabilizing component;

  • Reduces/eliminates need for dual anti-platelet therapy;

  • Simplified sizing approach compared to other intra-saccular devices (i.e. neck  and widest diameter only).

View case reports

Arrow-300dpi.png

How safe and effective are existing treatments for wide-necked bifurcation aneurysms?

 

Literature based objective performance criteria for safety and effectiveness 

Journal of Neurointerventional Surgery, October 11, 2017

Meta-Analysis, Fiorella et al.

Description                                           Outcome (1yr)

Wide Neck Bifurcation Aneurysm     2,795

Complete Occlusion                            40%

Adequate Occlusion                            70%

Conclusion:  Conventional therapies for WNBAs are associated with relatively low rates of complete occlusion and peri-procedural complications are not uncommon. Newer therapies are needed for the treatment of these aneurysms. Until a ‘gold standard’ treatment strategy is established, these emerging technologies can be evaluated in comparison to the benchmark literature-derived OPC presented*. 

What does it take to be a “big believer” in intrasaccular devices?

 

Tufail Patankar (UK) speaks about his personal experience with these effective tools, during the LINNC, Paris 2019 Congress.

Arrow-300dpi.png

Read or download the

Contour Launch Card

Indications for Use

The Contour Neurovascular System™ is indicated for the endovascular embolization of saccular intracranial aneurysms. 

The Contour Neurovascular System™, Models CNS0005-XX, CNS0007-XX, CNS0009XX and CNS0011-XX, meet the essential requirements referred to in Article 3 of the MDD 93/42/EEC and are labelled with the CE Marking of conformity.

Products are not available for sale in the United States.

Cerus Endovascular is an ISO 13485:2016 certified company. © 2019 Cerus Endovascular Inc. All rights reserved.

Tel: +1 (510) 651 4000

Cerus Endovascular Inc. 47757 Fremont Boulevard, Fremont, CA 94538 USA

APM007-01.S  3rd of August  2020